Aster DM Healthcare Q2 FY25: Revenue jumps 16% to Rs. 1,086 crore

Aster DM Healthcare has announced financial results for Q2 and H1 FY25.

Q2 FY 25 highlights:
Revenue increased 16% YoY to Rs 1,086 crore in Q2 FY25 compared to Rs 934 crore in Q2 FY24.

Operating EBITDA jumped 48% YoY to Rs 233 crore in Q2 FY25 compared to Rs 157 crore in Q2 FY24.

HIFY 25 highlights:
Revenue jumped 18% YoY to Rs 2,088 crore in H1 FY25 compared to Rs 1,772 crore in H1 FY24.

Operating EBITDA grew 44% YoY to Rs 410 crore in H1 FY25 compared to Rs 285 crore in H1 FY24.

Net profit jumped 88% to Rs 171 crore in H1 FY25 compared to Rs 91 crore in H1 FY24.

“We are pleased with the momentum built in the second quarter of FY25, which reflects our unwavering focus on operational excellence and capacity enhancement. In H1 FY25, our India business achieved 18% YoY growth, reaching INR 2,088 crores, driven by increased occupancy and growth in ARPOB. The Operating EBITDA grew by 44% YoY to INR 410 crores and net profits (post NCI) grew by 88% YoY to INR 171 crores in H1 FY25. The steady growth across our core businesses, combined with strategic cost optimization, has significantly strengthened our margins with H1FY25 Operating EBITDA margins standing at 19.6%,” said Commenting Dr Azad Moopen, Founder and Chairman, Aster DM Healthcare.

Dr Moopen noted: “As we expand, with plans to surpass ~6,800 beds by FY27, Aster DM Healthcare is well-positioned to meet the increasing demand for advanced healthcare in India. I am pleased to share that 9 Aster Hospitals are now accredited in the new Digital Standards Published by NABH signifying our commitment to Digital Transformation. Amongst them, 5 Hospitals have been accorded the highest accreditation in the Platinum category thus underscoring our leadership in digital healthcare transformation.”
MB Bureau